Candel Therapeutics Inc.
CADL | NASDAQ
$11.65
+$0.44 (+3.93%)
Sep 22, 2026, 11:07 AM ET · Market open
Market Data
Market Cap $821.36M
Enterprise Value $669.31M
Beta -0.47
Average Volume 1.71M
Shares Outstanding (Diluted) 74.13M
Shares Change YoY 43.97%
Institutional Ownership 69.64%
Exchange NASDAQ
ISIN US1374041093
Price Performance
Price Change 1M -13.6%
Price Change 3M 23.5%
Price Change 6M 124.7%
Price Change YTD 106.1%
Price Change 1Y 114.3%
Price Change 3Y 883.3%
Price Change 5Y 12.9%
1M CAGR (ann.) 5.8%
1Y CAGR (ann.) 126.9%
5Y CAGR (ann.) 6.2%
All-Time CAGR 9.6%
Valuation
PE Ratio -7.95
Forward PE N/A
PEG Ratio 0.10
Forward PEG 0.38
PS Ratio N/A
Forward PS 18.90
PB Ratio 6.51
P/FCF Ratio -14.33
P/Adj. FCF Ratio -12.82
P/OCF Ratio -14.75
EV/Sales N/A
EV/EBIT -10.98
EV/EBITDA -11.07
EV/FCF -11.68
Earnings Yield -12.6%
FCF Yield -7.0%
Adj. FCF Yield -7.8%
Financial Health
Net Cash $153.73M
Total Debt $49.52M
Cash & Short-Term Investments $201.57M
Total Assets $208.15M
Current Ratio 16.09
Quick Ratio 16.09
Debt / Equity Ratio 0.39
Debt / EBITDA -0.82
Debt / FCF -0.86
OCF / Debt -1.13
Interest Coverage -15.26
Altman Z-Score 4.27
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -11.8%
Returns
Return on Assets -42.5%
Return on Equity -89.4%
Return on Invested Capital -36.7%
Return on Capital Employed -36.8%
Return on Tangible Assets -42.5%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y -83.3%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 11.4%
EPS CAGR 5Y -6.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y -33.3%
FCF CAGR 5Y -14.1%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 76.1%
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.30
EPS Growth Est (next Q) 42.9%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $22.50
Price Target Upside 100.7%
Cash Flow
Operating Cash Flow $-56.02M
Free Cash Flow $-57.32M
Adj. Free Cash Flow $-64.08M
FCF Per Share -$0.77
OCF Per Share -$0.76
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-71.99M
EBITDA $-60.47M
Net Income $-88.53M
EPS (Diluted) -$1.41
Revenue / Employee N/A
Profit / Employee $-1.61M
Employees 55
Add to Watchlist
Select watchlists to add or remove CADL